COVID-19-induced vascular complications: mechanisms and potential therapies
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:1 publications
Grant number: 2010757
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$531,379.54Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
Dr. Emma GordonResearch Location
AustraliaLead Research Institution
University of QueenslandResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The coronavirus SARS-CoV-2 is responsible for the disease COVID-19, which causes significant lung dysfunction. Importantly, reports have observed COVID-19 symptoms that are not associated with the lungs, such as blood clots, vessel inflammation and leakage of fluid from vessels into tissues. These virus-induced vessel defects can lead to the death of patients. Here, we aim to understand exactly how these vessel defects occur to develop treatments for patients with acute and long term disease.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC